Catherine Coste's Net Worth

-$34.7 Thousand

Estimate Recalculated Apr 26, 2024 03:03PM EST

Who is Catherine Coste?

Catherine Coste does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOMERICA INC, MINERVA SURGICAL INC, and Renalytix plc.

SEC CIK

Catherine Coste's CIK is 0001821432

Past Insider Trading and Trends

2023 was Catherine Coste's most active year for acquiring shares with 5 total transactions. Catherine Coste's most active month to acquire stocks was the month of November. 2022 saw Catherine Coste paying a total of $119,998.72 for 49,792 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOMERICA INC (BMRA) Snapshot price: $0.8729

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Apr 20
Form 4
+5.26%
2.19K
$2.96
$6,482.40
43.79K
Jan 26
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Dec 10
Form 4
∞
9.1K
$5.45
$49,595.00
9.1K
Oct 26
Form 3
—
0
—
—
0
No matching records found

MINERVA SURGICAL INC (UTRS) Snapshot price: $0.735

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+62.41%
49.79K
$2.41
$119,998.72
129.58K
Jun 10
Form 3
—
0
—
—
0
No matching records found

Renalytix plc (RNLX) Snapshot price: $0.2687

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 20
Form 4
—
0
—
—
0
Jul 6
Form 3
—
0
—
—
0
No matching records found